CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield
Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E's CORBEVAX as a heterologous booster for adults above 18 yrs old.
Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E's CORBEVAX as a heterologous booster for adults above 18 yrs old.
Biological E Limited has manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the Central Government.
In addition to receiving financial assistance under Mission Covid Suraksha, this vaccine candidate has also obtained financial support under Covid-19 Research Consortia through the BIRAC's National Biopharma Mission.
The trial will be on children between 5 and 18 years of age with certain conditions and conducted in 10 locations across the country,
